内科学
内分泌学
医学
代谢综合征
血压
肾
肾功能
碳水化合物代谢
肾切除术
炎症
心功能曲线
病理生理学
生理学
肥胖
心力衰竭
作者
Lucas Rannier Ribeiro Antonino Carvalho,Miho Shimari,Ariela Maína Boeder,Zhengbing Zhuge,Min Cai,Cecilia Leijding,Stefano Gastaldello,Andrei L. Kleschyov,Tomas A. Schiffer,Drielle D. Guimarães,Giulia Picozzi,Lars H. Lund,Bengt Fellstrøm,Eddie Weitzberg,Jon O. Lundberg,Carolina E. Hagberg,Gianluigi Pironti,Daniel Andersson,Mattias Carlström
出处
期刊:Lab Animal
[Springer Nature]
日期:2024-10-22
卷期号:53 (11): 336-346
被引量:1
标识
DOI:10.1038/s41684-024-01457-5
摘要
Abstract The aim of this study was to explore biological interaction and pathophysiology mechanisms in a new mouse model of cardiovascular–kidney–metabolic (CKM) syndrome, induced by chronic moderate renal failure in combination with consumption of a customized Western diet rich in carbohydrates, fat and salt. Male C57BL/6J mice were subjected to unilateral nephrectomy, fed a customized Western diet rich not only in sugar and fat but also in salt, and followed for 12 weeks or 20 weeks. Sham-operated mice on a standard chow served as healthy controls. Body composition, weight gain, glucose metabolism, fat distribution, blood pressure, cardiac function, vascular reactivity, renal function, inflammation and mitochondrial function were measured and combined with biochemical and histopathological analyses. The novel triple-hit model of CKM syndrome showed signs and symptoms of metabolic syndrome, disturbed glucose metabolism, impaired adipocyte physiology and fat redistribution, cardiovascular dysfunction, renal damage and dysfunction, systemic inflammation, elevated blood pressure and cardiac remodeling. The pathological changes were more pronounced in mice after prolonged exposure for 20 weeks, but no deaths occurred. In the present mouse model of CKM syndrome, profound and significant metabolic, cardiac, vascular and renal dysfunctions and injuries emerged by using a Western diet rich not only in fat and carbohydrates but also in salt. This multisystem disease model could be used for mechanistic studies and the evaluation of new therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI